The Group's activity ranges from the preliminary research needed to develop and optimise the production of a medicinal product to the integral management of its distribution and promotion.
Grupo Farmasierra carries out contract manufacturing and technology development services at the international level for the entire European Union, Russia, Israel, Australia, New Zealand and Japan.
Moreover, it provides third parties with distribution services at the national level and commercialises its products in Spain and Portugal.
The on-going incorporation of new knowledge is key to the consolidation of all its areas and its expansion over time. Therefore, Grupo Farmasierra attends major international forums on galenic and pharmaceutical innovation and is in contact with the main sources of specialised information, including among others, the Autonomous University of Madrid, the University de Alcala de Henares, University San Pablo CEU, the University of Barcelona and University of Salamanca.
Since the founding of the company in 1996, the growing activity of the Production and Technology Development Areas has led Grupo Farmasierra to participate on a continual basis in collaborative international projects with prestigious companies in the U.S., England, Sweden, Germany, Italy and Spain.
Its technology projects are financially supported by public institutions such as the Centre for the Development of Industrial Technology (CDTI) and the Autonomous Community of Madrid.
In its commitment to quality, innovation and social responsibility, Grupo Farmasierra holds Good Manufacturing Practices certificates, authorisation as a pharmaceutical research manufacturer, the British Standards Institution (BSI)'s ISO-14001 environmental management system certificate and the Self-Protection Plan.
The Farmasierra Products is continuously growing and available to healthcare professionals. It is organised into families that are augmented by new products, thanks to the intense activity of our Research and Development Departments.
Grupo Farmasierra's plan for the future is based on harnessing the potential of its four activity areas (R&D&I, Manufacturing, Distribution and Commercialisation) for which it makes on-going investments in technology, new products, the generation of industrial property and commercial development on its own behalf and via international licenses.
Grupo Farmasierra carries out contract manufacturing and technology development services at the international level for the entire European Union, Russia, Israel, Australia, New Zealand and Japan.
Moreover, it provides third parties with distribution services at the national level and commercialises its products in Spain and Portugal.
The on-going incorporation of new knowledge is key to the consolidation of all its areas and its expansion over time. Therefore, Grupo Farmasierra attends major international forums on galenic and pharmaceutical innovation and is in contact with the main sources of specialised information, including among others, the Autonomous University of Madrid, the University de Alcala de Henares, University San Pablo CEU, the University of Barcelona and University of Salamanca.
Since the founding of the company in 1996, the growing activity of the Production and Technology Development Areas has led Grupo Farmasierra to participate on a continual basis in collaborative international projects with prestigious companies in the U.S., England, Sweden, Germany, Italy and Spain.
Its technology projects are financially supported by public institutions such as the Centre for the Development of Industrial Technology (CDTI) and the Autonomous Community of Madrid.
In its commitment to quality, innovation and social responsibility, Grupo Farmasierra holds Good Manufacturing Practices certificates, authorisation as a pharmaceutical research manufacturer, the British Standards Institution (BSI)'s ISO-14001 environmental management system certificate and the Self-Protection Plan.
The Farmasierra Products is continuously growing and available to healthcare professionals. It is organised into families that are augmented by new products, thanks to the intense activity of our Research and Development Departments.
Grupo Farmasierra's plan for the future is based on harnessing the potential of its four activity areas (R&D&I, Manufacturing, Distribution and Commercialisation) for which it makes on-going investments in technology, new products, the generation of industrial property and commercial development on its own behalf and via international licenses.
